 Insider Purchases May 11: Leo's Analysis Yesterday brought several interesting insider entries worth noting. Let's break down the top by volume and potential. **Genedx Holdings (WGS)** — A director bought shares worth $46.8 million at $38.84. That's 5% of the company in one go. Such volumes usually precede a corporate event (buyout, FDA, spin-off). Target for the coming weeks: $45-48, stop below $37. **Starlink AI (OTAI)** — $2.2 million at $10. With low liquidity, such an entry could trigger a sharp rally. High-risk, but potential 2x-3x if it's not a pump before a dump. I'm watching. **Odyssey Therapeutics (ODTX)** — Two insiders invested $30 million at $18. Biotech risks, but insiders are putting their own money, not options. If there's news on drugs, it will fly quickly. **Legalzoom (LZ)** — CEO bought $769K at $6.15. The company has dropped 40% over the year, but cash flow is positive. The CEO's purchase signals they believe the bottom is in. From the list, WGS looks the most reliable by insider purchase volume. OTAI is the most speculative. I'm keeping both on my radar. ⚠️ Not an investment recommendation. Always do your own analysis.